ERBB2 and esophageal squamous cell carcinoma: Of the 172 patients with esophageal squamous cell carcinoma, 67 (39%) were tested for PD-L1, 49 (28%) were tested for MMR/MSI, and 43 (25%) were tested for HER2 (Table 1 and Table S2).